Barclays’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $173K | Sell |
9,635
-48,109
| -83% | -$965K | ﹤0.01% | 3774 |
|
|
2025
Q4 | $1.35M | Buy |
57,744
+2,125
| +4% | +$46.1K | ﹤0.01% | 3226 |
|
|
2025
Q3 | $1.11M | Sell |
55,619
-14,535
| -21% | -$261K | ﹤0.01% | 3299 |
|
|
2025
Q2 | $961K | Buy |
70,154
+25,614
| +58% | +$246K | ﹤0.01% | 3363 |
|
|
2025
Q1 | $493K | Sell |
44,540
-24,785
| -36% | -$264K | ﹤0.01% | 3541 |
|
|
2024
Q4 | $738K | Buy |
69,325
+9,547
| +16% | +$114K | ﹤0.01% | 3581 |
|
|
2024
Q3 | $759K | Buy |
59,778
+48,040
| +409% | +$713K | ﹤0.01% | 3533 |
|
|
2024
Q2 | $197K | Sell |
11,738
-7,674
| -40% | -$109K | ﹤0.01% | 3587 |
|
|
2024
Q1 | $291K | Sell |
19,412
-17,955
| -48% | -$293K | ﹤0.01% | 3917 |
|
|
2023
Q4 | $561K | Buy |
37,367
+33,946
| +992% | +$441K | ﹤0.01% | 3808 |
|
|
2023
Q3 | $47.9K | Sell |
3,421
-480
| -12% | -$7.71K | ﹤0.01% | 3890 |
|
|
2023
Q2 | $40.4K | Sell |
3,901
-4,247
| -52% | -$46.9K | ﹤0.01% | 3923 |
|
|
2023
Q1 | $75.3K | Sell |
8,148
-6,451
| -44% | -$59.4K | ﹤0.01% | 4317 |
|
|
2022
Q4 | $129K | Buy |
14,599
+10,817
| +286% | +$102K | ﹤0.01% | 4081 |
|
|
2022
Q3 | $31K | Hold |
3,782
| – | – | ﹤0.01% | 3931 |
|
|
2022
Q2 | $31K | Sell |
3,782
-3,169
| -46% | -$21.8K | ﹤0.01% | 4236 |
|
|
2022
Q1 | $61K | Sell |
6,951
-20,508
| -75% | -$160K | ﹤0.01% | 4035 |
|
|
2021
Q4 | $261K | Buy |
27,459
+15,699
| +133% | +$221K | ﹤0.01% | 3470 |
|
|
2021
Q3 | $198K | Buy |
11,760
+5,060
| +76% | +$80.2K | ﹤0.01% | 3629 |
|
|
2021
Q2 | $102K | Sell |
6,700
-13,368
| -67% | -$242K | ﹤0.01% | 3836 |
|
|
2021
Q1 | $392K | Buy |
20,068
+9,490
| +90% | +$201K | ﹤0.01% | 3328 |
|
|
2020
Q4 | $191K | Sell |
10,578
-2,480
| -19% | -$52K | ﹤0.01% | 3784 |
|
|
2020
Q3 | $252K | Sell |
13,058
-2,693
| -17% | -$61K | ﹤0.01% | 3694 |
|
|
2020
Q2 | $412K | Buy |
15,751
+5,367
| +52% | +$131K | ﹤0.01% | 3498 |
|
|
2020
Q1 | $185K | Sell |
10,384
-9,369
| -47% | -$253K | ﹤0.01% | 4368 |
|
|
2019
Q4 | $660K | Buy |
19,753
+9,799
| +98% | +$267K | ﹤0.01% | 4051 |
|
|
2019
Q3 | $237K | Sell |
9,954
-2,172
| -18% | -$71K | ﹤0.01% | 4846 |
|
|
2019
Q2 | $436K | Sell |
12,126
-18,437
| -60% | -$680K | ﹤0.01% | 4442 |
|
|
2019
Q1 | $1.13M | Buy |
30,563
+9,282
| +44% | +$389K | ﹤0.01% | 3282 |
|
|
2018
Q4 | $916K | Buy |
21,281
+1,281
| +6% | +$57.6K | ﹤0.01% | 3207 |
|
|
2018
Q3 | $945K | Sell |
20,000
-2,600
| -12% | -$121K | ﹤0.01% | 3683 |
|
|
2018
Q2 | $1.12M | Sell |
22,600
-2,400
| -10% | -$140K | ﹤0.01% | 3156 |
|
|
2018
Q1 | $1.24M | Buy |
+25,000
| New | +$1.25M | ﹤0.01% | 2960 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
